Article

Sexual Dysfunction in Multiple Myeloma

Tiffany Richards

Page A. Bertolotti

Deborah Doss

Emily J. McCullagh

the International Myeloma Foundation Nurse Leadership Board

sexuality, sexuality and fertility, multiple myeloma
CJON 2011, 15(4), 53-65. DOI: 10.1188/11.CJON.S1.53-65

The World Health Organization describes sexuality as a "central aspect of being human throughout life and encompasses sex, gender identities and roles, sexual orientation, eroticism, pleasure, intimacy, and reproduction. Sexuality is influenced by the interaction of biological, psychological, social, economic, political, cultural, ethical, legal, historical, religious, and spiritual factors." Currently, no research has been conducted regarding sexual dysfunction in patients with multiple myeloma; therefore, information related to the assessment and evaluation of sexual dysfunction is gleaned from other malignancies and diseases. In this article, members of the International Myeloma Foundation's Nurse Leadership Board discuss the definition, presentation, and causes of sexual dysfunction; provide recommendations for sexual assessment practices; and promote discussion among patients with multiple myeloma, their healthcare providers, and their partners.

Jump to a section

    References

    American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
    Anantharaman, P., & Schmidt, R.J. (2007). Sexual function in chronic kidney disease. Advances in Chronic Kidney Disease, 14, 119-125. doi:10.1053/j.ackd.2007.01.002
    Aung, H.H., Dey, L., Rand, V., & Yuan, C.S. (2004). Alternative therapies for male and female sexual dysfunction. American Journal of Chinese Medicine, 32, 161-173. doi:10.1142/S0192415X04001837
    Basson, R. (2001). Using a different model for female sexual response to address women's problematic low sexual desire. Journal of Sex and Marital Therapy, 27, 395-403. doi:10.1080/713846827
    Basson, R., & Schultz, W.W. (2007). Sexual sequelae of general medical disorders. Lancet, 369, 409-424. doi:10.1016/S0140-6736 (07)60197-4
    Bhasin, S., Enzlin, P., Coviello, A., & Basson, R. (2007). Sexual dysfunction in men and women with endocrine disorders. Lancet, 369, 597-611. doi:10.1016/S0140-6736(07)60280-3
    Bonfils, S., Mignon, M., Vallot, & Mayeur, S. (1981). Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome. Scandinavian Journal of Gastroenterology. Supplement, 69, 119-123.
    Brock, G.B., & Lue, T.F. (1993). Drug-induced male sexual dysfunction. An update. Drug Safety, 8, 414-426. doi:10.2165/00002018-199308060-00003
    Bruner, D., & Berk, L. (2004). Altered body image and sexual health (3rd ed.). Sudbury, MA: Jones and Bartlett.
    Bruner, D.W., & Calvano, T. (2007). The sexual impact of cancer and cancer treatments in men. Nursing Clinics of North America, 42, 555-580. doi:10.1016/j.cnur.2007.07.005
    Carvajal, A., Lerida, M.T., Sanchez, A., Martin, L.H., & de Diego, I.M. (1995). ACE inhibitors and impotence: A case series from the Spanish drug monitoring system. Drug Safety, 13, 130-131.
    Celgene Corp. (2010a) Revlimid® (lenalidomide) [Product information]. Summit, NJ: Author.
    Celgene Corp. (2010b) Thalomid® (thalidomide) [Product information]. Summit, NJ: Author.
    Chatterjee, R., Andrews, H.O., McGarrigle, H.H., Kottaridis, P.D., Lees, W.R., Mackinnon, S., … Goldsone, A.H. (2000). Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies. Bone Marrow Transplant, 25, 1185-1189. doi:10.1038/sj.bmt.1702391
    Clayton, A., & Ramamurthy, S. (2008). The impact of physical illness on sexual dysfunction. Advances in Psychosomatic Medicine, 29, 70-88. doi:10.1159/000126625
    Coker, A.L. (2007). Does physical intimate partner violence affect sexual health? A systematic review. Trauma, Violence, and Abuse, 8, 149-177. doi:10.1177/1524838007301162
    Contreras, L.N., Masini, A.M., Danna, M.M., Kral, M., Bruno, O.D., Rossi, M.A., & Andrada, J.A. (1996). Glucocorticoids: Their role on gonadal function and LH secretion. Minerva Endocrinologica, 21, 43-46.
    Coyne, K.S., Sexton, C.C., Irwin, D.E., Kopp, Z.S., Kelleher, C.J., & Milsom, I. (2008). The impact of overactive bladder, incontinence, and other lower urinary tract symptoms on quality of life, work productivity, sexuality, and emotional well-being in men and women: Results from the EPIC study. British Journal of Urology International, 101, 1388-1395.
    Davis, S., & Tran, J. (2001). What are "normal" testosterone levels for women? Journal of Clinical Endocrinology and Metabolism, 86, 1842-1843. doi:10.1210/jc.86.4.1842
    Davis, S.R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., … the APHRODITE Study Team. (2008). Testosterone for low libido in postmenopausal women not taking estrogen. New England Journal of Medicine, 359, 2005-2017. doi:10.1056/NEJMoa0707302
    DeFrank, J.T., Mehta, C.C., Stein, K.D., & Baker, F. (2007). Body image dissatisfaction in cancer survivors [Online exclusive]. Oncology Nursing Forum, 34, E36-E41. doi:10.1188/07.ONF.E36-E41
    de Savary, N., Lee, R., & Vaidya, B. (2004). Severe hypothyroidism after thalidomide treatment. Journal of the Royal Society of Medicine, 97, 443. doi:10.1258/jrsm.97.9.443
    Do, C., Huyghe, E., Lapeyre-Mestre, M., Montastruc, J.L., & Bagheri, H. (2009). Statins and erectile dysfunction: Results of a case/noncase study using the French Pharmacovigilance System Database. Drug Safety, 32, 591-597. doi:10.2165/00002018-2009320 70-00005
    Doumas, M., Tsiodras, S., Tsakiris, A., Douma, S., Chounta, A., Papadopoulos, A., … Giamerellou, H. (2006). Female sexual dysfunction in essential hypertension: A common problem being uncovered. Journal of Hypertension, 24, 2387-2392. doi:10.1097/01.hjh.0000251898.40002.5b
    Faiman, B., Bilotti, E., Mangan, P.A., Rogers, K., & the International Myeloma Foundation Nurse Leadership Board. (2008). Steroid-associated side effects in patients with multiple myeloma: Consensus statement of the IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing, 12(3, Suppl.), 53-63. doi:10.1188/08.CJON.S1.53-62
    Fentiman, I.S., Thomas, B.S., Balkwill, F.R., Rubens, R.D., & Hayward, J.L. (1985). Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet, 1, 1166. doi:10.1016/S0140-6736(85)92475-4
    Fischbach, F. (2000). A manual of laboratory and diagnostic tests (6th ed.). Philadelphia, PA: Lippincott Williams and Wilkins.
    Fourcroy, J.L. (2003). Female sexual dysfunction: Potential for pharmacotherapy. Drugs, 63, 1445-1457. doi:10.2165/00003495-200363140-00002
    Fourcroy, J.L. (2006). Customs, culture, and tradition—What role do they play in a woman's sexuality? Journal of Sexual Medicine, 3, 954-959. doi:10.1111/j.1743-6109.2006.00322.x
    Frank, J.E., Mistretta, P., & Will, J. (2008). Diagnosis and treatment of female sexual dysfunction. American Family Physician, 77, 635-642.
    Ganz, P.A., & Greendale, G.A. (2007). Female sexual desire—Beyond testosterone. Journal of the National Cancer Institute, 99, 659-661. doi:10.1093/jnci/djk175
    Gevirtz, C. (2008). How chronic pain affects sexuality. Nursing, (January), 17.
    Hansen, K.A. (2003). Laboratory studies in the evaluation of urologic disease: Part I. Urologic Nursing, 23, 400-404.
    Harsh, V., McGarvey, E.L., & Clayton, A.H. (2008). Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: A pilot study. Journal of Sexual Medicine, 5, 640-645. doi:10.1111/j.1743-6109.2007.00746.x
    Hitiris, N., Barrett, J.A., & Brodie, M.J. (2006). Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: Five case reports. Epilepsy and Behavior, 8, 418-421. doi:10.1016/j.yebeh.2005.12.001
    Hughes, M.K. (2008). Alterations of sexual function in women with cancer. Seminars in Oncology Nursing, 24, 91-101. doi:10.1016/j.soncn.2008.02.003
    Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St. John's Wort) in major depressive disorder. A randomized controlled trial. JAMA, 287, 1807-1814. doi:10.1001/jama.287.14.1807
    Isoardo, G., Bergui, M., Durelli, L., Barbero, P., Boccadoro, M., Bertola, A., … Cocito, D. (2004). Thalidomide neuropathy: Clinical, electrophysiological, and neuroradiological features. Acta Neurologica Scandinavica, 109, 188-193. doi:10.1034/j.1600-0404 .2003.00203.x
    Kagan, S.H., Holland, N., & Chalian, A.A. (2008). Sexual issues in special populations: Geriatric oncology—Sexuality and older adults. Seminars in Oncology Nursing, 24, 120-126. doi:10.1016/j.soncn.2008.02.005
    Kalantaridou, S.N., & Calis, K.A. (2006). Testosterone therapy in premenopausal women. Seminars in Reproductive Medicine, 24, 106-114. doi:10.1055/s-2006-939569
    Kandeel, F.R., Koussa, V.K.T., & Swerdloff, R.S. (2001). Male sexual function and its disorders: Physiology, pathophysiology, clinical investigation, and treatment. Endocrine Reviews, 22, 342-388. doi:10.1210/er.22.3.342
    King, L., Quinn, G.P., Vadaparampil, S.T., Gwede, C.K., Miree, C.A., Wilson, C., … Perrin, K. (2008). Oncology nurses' perceptions of barriers to discussion of fertility preservation with patients with cancer. Clinical Journal of Oncology Nursing, 12, 467-476. doi:10.1188/08.CJON.467-476
    Kingsberg, S. (2004). Just ask! Talking to patients about sexual function. Sexuality, Reproduction, and Menopause, 2, 199-203. doi:10.1016/j.sram.2004.11.007
    Krychman, M.L., Carter, J., Aghajanian, C.A., Dizon, D.S., & Castiel, M. (2004). Chemotherapy-induced dyspareunia: A case study of vaginal mucositis and pegylated liposomal doxorubicin injection in advanced stage ovarian carcinoma. Gynecologic Oncology, 93, 561-563. doi:10.1016/j.ygyno.2004.02.001
    Kwan, K.S.H., Roberts, L.J., & Swalm, D.M. (2005). Sexual dysfunction and chronic pain: The role of psychological variables and impact on quality of life. European Journal of Pain, 9, 643-652. doi:10.1016/j.ejpain.2004.12.008
    Kyle, R.A., & Rajkumar, S.V. (2009). Treatment of multiple myeloma: A comprehensive review. Clinical Journal of Lymphoma and Myeloma, 9, 278-288. doi:10.3816/CLM.2009.n.056
    Laaksonen, S., Remes, K., Koskela, K., Voipio-Pulkki, L.M., & Falck, B. (2005). Thalidomide therapy and polyneuropathy in myeloma patients. Electromyography and Clinical Neurophysiology, 45, 75-86.
    Lane, R.D., & Thayer, J.F. (2008). Sexual dysfunction and coronary artery disease: What applies to the gander may apply to the goose. American Journal of Medicine, 121, 256-257. doi:10.1016/j.amjmed.2008.02.005
    Lardinois, C.K., & Mazzaferri, E.L. (1985). Cimetidine blocks testosterone synthesis. Archives of Internal Medicine, 145, 920-922. doi:10.1001/archinte.145.5.920
    Lee, S.J., Schover, L.R., Partridge, A.H., Patrizio, P., Wallace, W.H., Hagerty, K., … Oktay, K. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology, 24, 2917-2931. doi:10.1200/JCO.2006.06.5888
    Manolis, A., & Doumas, M. (2008). Sexual dysfunction: The "prima ballerina" of hypertension-related quality-of-life complications. Journal of Hypertension, 26, 2074-2084. doi:10.1097/HJH.0b013e32830dd0c6
    Margo, K., & Winn, R. (2006). Testosterone treatments: Why, when, and how? American Family Physician, 73, 1591-1598.
    Masters, W.H., & Johnson, V.E. (1960). The human female: Anatomy of sexual response. Minnesota Medicine, 43, 31-36.
    Mayer, M.E., Bauer, R.M., Schorsch, I., Sonnenberg, J.E., Stief, C.G., & Uckert, S. (2007). Female sexual dysfunction: What's new? Current Opinions in Obstetrics and Gynecology, 19, 536-540. doi:10.1097/GCO.0b013e3282f1c733
    McCall-Hosenfeld, J.S., Freund, K.M., Legault, C., Jaramillo, S.A., Cochrane, B.B., Manson, J.E., … Bonds, D. (2008). Sexual satisfaction and cardiovascular disease: The women's health initiative. American Journal of Medicine, 121, 295-301. doi:10.1016/j.amjmed .2007.11.013
    McVary, K.T. (2007). Erectile dysfunction. New England Journal of Medicine, 357, 2472-2481. doi:10.1056/NEJMcp067261
    Menon, S., Habermann, T., & Witzig, T. (2007). Lenalidomide-associated hypothyroidism. Leukemia and Lymphoma 48, 2465-2467. doi:10.1080/10428190701704613
    Miceli, T., Colson, K., Gavino, M., Lilleby, K., & the International Myeloma Foundation Nurse Leadership Board. (2008). Myelosuppression associated with novel therapies in patients with multiple myeloma: Consensus statement of the IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing, 12(3, Suppl.), 13-19. doi:10.1188/08.CJON.S1.13-19
    Mick, J.M. (2007). Sexuality assessment: 10 strategies for improvement. Clinical Journal of Oncology Nursing, 11, 671-675. doi:10.1188/07.CJON.671-675
    Millennium: The Takeda Oncology Company. (2010). Velcade® (bortezomib) [Product information]. Cambridge, MA: Author.
    Murphy, P.T., & O'Donnell, J.R. (2007). Thalidomide induced impotence in male hematology patients: A common but ignored complication? Haematologica, 92, 1440. doi:10.3324/haematol.11095
    National Menopause Society. (2005). The role of testosterone therapy in postmenopausal women: Position statement of The North American Menopause Society. Menopause, 12, 497-511.
    Nappi, R.E., & Lachowsky, M. (2009). Menopause and sexuality: Prevalence of symptoms and impact on quality of life. Maturitas, 63, 138-141. doi:10.1016/j.maturitas.2009.03.021
    Pierce, J.R., Jr. (1983). Cimetidine-associated depression and loss of libido in a woman. American Journal of Medical Sciences, 286, 31-34. doi:10.1097/00000441-198311000-00005
    Quesada, J.R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J.U. (1986). Clinical toxicity of interferons in cancer patients: A review. Journal of Clinical Oncology, 4, 234-243.
    Reffelmann, T., & Kloner, R.A. (2006). Sexual function in hypertensive patients receiving treatment. Vascular Health Risk Management, 2, 447-455. doi:10.2147/vhrm.2006.2.4.447
    Sáenz de Tejada, I., Javier, A., Selim, C., Nestor, G.C., Jeremy, H., Robert, P., … Simonsen, U. (2005). Pathophysiology of erectile dysfunction. Journal of Sexual Medicine, 2, 26-39. doi:10.1111/j.1743-6109.2005.20103.x
    Santucci, L., Farroni, F., Fiorucci, S., & Morelli, A. (1991). Gynecomastia during omeprazole therapy. New England Journal of Medicine, 324, 635. doi:10.1056/NEJM199102283240916
    Schover, L.R. (1999). Counseling cancer patients about changes in sexual function. Oncology, 13, 1585-1591.
    Shabsigh, R., & Rowland, D. (2007). The Diagnostic and Statistical Manual of Mental Disorders (4th ed.) text revision as an appropriate diagnostic for premature ejaculation. Journal of Sexual Medicine, 4, 1468-1478. doi:10.1111/j.1743-6109.2007.00557.x
    Shell, J. (2002). Evidence-based practice for symptom management in adults with cancer: Sexual dysfunction. Oncology Nursing Forum, 29, 53-66. doi:10.1188/02.ONF.53-69
    Shell, J.A. (2007). Including sexuality in your nursing practice. Nursing Clinics of North America, 42, 685-696. doi:10.1016/j.cnur .2007.08.007
    Shifren, J.L. (2004). The role of androgens in female sexual dysfunction. Mayo Clinic Proceedings, 79(4, Suppl.), S19-S24.
    Smith, P.J., & Talbert, R.L. (1986). Sexual dysfunction with antihypertensive and antipsychotic agents. Clinical Pharmacology, 5, 373-384.
    Srivastava, R., Thakar, R., & Sultan, A. (2008). Female sexual dysfunction in obstetrics and gynecology. Obstetrical and Gynecological Survey, 63, 527-537. doi:10.1097/OGX.0b013e31817f13e3
    Tariman, J.D., Love, G., McCullagh, E., Sandifer, S., & the International Myeloma Foundation Nurse Leadership Board. (2008). Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: Consensus statement of the IMF Nurse Leadership Board. Clinical Journal of Oncology Nursing, 12(3, Suppl.), 29-35. doi:10.1188/08.CJON.S1.29-35
    Tauchmanovà, L., Selleri, C., De Rosa, G., Esposito, M., Di Somma, C., Orio, F., … Colao, A. (2005). Endocrine disorders during the first year after autologous stem-cell transplant. American Journal of Medicine, 118, 664-670. doi:10.1016/j.amjmed.2005.02.009
    Taylor, B., & Davis, S. (2006). Using the Extended PLISSIT model to address sexual healthcare needs. Nursing Standard, 21, 35-40.
    Taylor, M.J., Rudkin, L., & Hawton, K. (2005). Strategies for managing antidepressant-induced sexual dysfunction: Systematic review of randomised controlled trials. Journal of Affective Disorders, 88, 241-254. doi:10.1016/j.jad.2005.07.006
    Tierney, K.D., Facione, N., Padilla, G., Blume, K., & Dodd, M. (2007). Altered sexual health and quality of life in women prior to hematopoietic cell transplantation. European Journal of Oncology Nursing, 11, 298-308. doi:10.1016/j.ejon.2006.10.009
    Tomlinson, J. (1998). ABC of sexual health. Taking a sexual history. BMJ, 317, 1573-1576.
    White, A., Hayhoe, S., Hart, A., Ernst, E., & volunteers from BMAS and AACP. (2001). Adverse events following acupuncture (SAFA): A prospective survey of 32,000 consultations. Acupuncture in Medicine 19, 84-92. doi:10.1136/aim.19.2.84
    Zator Estes, M.E. (2002). Nursing tip: Dealing with sensitive topics (2nd ed.). Albany, NY: Delmar Thomson Learning.
    Zeldis, J.B., Williams, B.A., Thomas, S.D., & Elsayed, M.E. (1999). S.T.E.P.S.™: A comprehensive program for controlling and monitoring access to thalidomide. Clinical Therapeutics, 21, 319-330. doi:10.1016/S0149-2918(00)88289-2
    Zemishlany, Z., & Weizman, A. (2008). The impact of mental illness on sexual dysfunction. Advances in Psychosomatic Medicine, 29, 89-106. doi:10.1159/000126626